References
- Une T, Fujimoto T, Sato K, Osada Y. In vitro activity of DR-3355, an optically active ofloxacin. Antimicrob Agents Chemother 1988; 32: 1336–40.
- Hayakawa I, Atarashi S, Yokohama S, Imamura M, Sakano K, Furukawa M. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother 1986; 29: 163–4.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Second edition. Approved Standard. NCCLS document M7-A2. NCCLS, Villanova, Pa., 1990.
- Neu HC, Chin N-X. In vitro activity of S-ofloxacin. Antimicrob Agents Chemother 1989; 33: 1105–7.
- Fujimoto T, Mitsuhashi S. In vitro antibacterial activity of DR- 3355, the S-(-)-isomer of ofloxacin. Chemotherapy 1990; 36: 268–76.
- Tanaka M, Otsuki M, Une T, Nishino T. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin. J Antimicrob Chemother 1990; 26: 659–66.
- Imamura M, Shibamura S, Hayakawa I, Osada Y. Inhibition of DNA gyrase by optically active ofloxacin. Antimicrob Agents Chemother 1987; 31: 325–7.
- Wolfson JS, Hooper DC, Ng EY, Souza KS, McHugh GL, Swartz MN. Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers. Antimicrob Agents Chemother 1987; 31: 1861–3.
- Gargallo-Viola D, Esteve M, Llovera S, Roca X, Guinea J. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3- methyl-azetidinyl tricyclic fluoroquinolone. Antimicrob Agents Chemother 1991; 35: 442–7.
- Miline LM, Faiers MC. Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus. Lancet 1988; 2: 843.
- Shalit I, Berger SA, Gorea A, Frimerman H. Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrob Agents Chemother 1989; 33: 543–4.
- Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA. Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 1990; 34: 1862–3.
- Maple PAC, Hamilton-Miller JMT, Brumfitt W. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin- resistant, methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1991; 35: 345–50.
- Neu HC. Bacterial resistance to fluoroquinolones. Rev Infect Dis 1988; 10 (suppl 1): 57–63.
- Fujimaki K, Fujii T, Aoyama H, et al. Quinolone resistance in clinical isolates of Serratia marcescens. Antimicrob Agents Chemother 1989; 33: 785–7.
- Parry MF, Pazer KB, Yokna ME. Quinolone resistance: Susceptibility data from a 300-bed community hospital. Am J Med 1989; 87 (suppl 5A): 12–6.
- Tanaka M, Une T, Osada Y. Sub-inhibitory and postantibiotic effects of an optically active isomer of ofloxacin. Arzneim-Forsch/Drug Res 1989; 39: 750–4.
- Fu KP, Lafredo SC, Foleno B, et al. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin. Antimicrob Agents Chemother 1992; 36: 860–6.